|
|
||||||||
ORIGINAL RESEARCH COMMUNICATIONS |
1 From the Department of Human Nutritional Sciences, University of Manitoba, Winnipeg, Canada.
Background: The addition of arachidonic acid (AA) and docosahexaenoic acid (DHA) to infant formula was recently approved in North America. In piglets, dietary AA is linked to elevations in bone mass.
Objective: The objective was to investigate the effects of varied amounts of dietary AA on bone modeling and bone mass with the use of the piglet model for infant nutrition.
Design: Male piglets (n = 32) were randomly assigned to receive 1 of 4 formulas supplemented with AA (0.30%, 0.45%, 0.60%, or 0.75% of fat) plus DHA (0.1% of fat) from days 5 to 20 of life. Measurements included biomarkers of bone modeling, fatty acid status, and whole-body and femur bone mineral content; bone area was measured by dual-energy X-ray absorptiometry. Differences among groups were detected with two-factor analysis of variance. Regression analyses were used to determine factors responsible for bone mineral content after dietary AA was accounted for.
Results: Proportions of AA in plasma, liver, and adipose were modified by the dietary treatments, but bone modeling was not affected. Liver AA was positively related to plasma insulin-like growth factor 1 and calcitriol and urinary N-telopeptide. Whole-body bone mineral content was elevated in the piglets fed 0.60% and 0.75% AA and was best predicted by dietary AA and bone resorption.
Conclusions: This study confirms that dietary AA alters bone mass and clarifies the best amount of AA to add to the diet of pigs born at term. Because the amount of dietary DHA was held constant, whether other amounts of DHA are related to bone mass requires investigation.
Key Words: Arachidonic acid bone growth piglet
This article has been cited by other articles:
![]() |
S. Ramanadham, K. E. Yarasheski, M. J. Silva, M. Wohltmann, D. V. Novack, B. Christiansen, X. Tu, S. Zhang, X. Lei, and J. Turk Age-Related Changes in Bone Morphology Are Accelerated in Group VIA Phospholipase A2 (iPLA2{beta})-Null Mice Am. J. Pathol., April 1, 2008; 172(4): 868 - 881. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Poulsen, P. J. Moughan, and M. C. Kruger Long-Chain Polyunsaturated Fatty Acids and the Regulation of Bone Metabolism Experimental Biology and Medicine, November 1, 2007; 232(10): 1275 - 1288. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bassaganya-Riera, A. J Guri, A. M Noble, K. A Reynolds, J. King, C. M Wood, M. Ashby, D. Rai, and R. Hontecillas Arachidonic acid and docosahexaenoic acid enriched formulas modulate antigen-specific T cell responses to influenza virus in neonatal piglets Am. J. Clinical Nutrition, March 1, 2007; 85(3): 824 - 836. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gu, S. E. House, R. L. Prior, N. Fang, M. J. J. Ronis, T. B. Clarkson, M. E. Wilson, and T. M. Badger Metabolic Phenotype of Isoflavones Differ among Female Rats, Pigs, Monkeys, and Women J. Nutr., May 1, 2006; 136(5): 1215 - 1221. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Mollard, M. E. Gillam, T. M. Wood, C. G. Taylor, and H. A. Weiler (n-3) Fatty Acids Reduce the Release of Prostaglandin E2 from Bone but Do Not Affect Bone Mass in Obese (fa/fa) and Lean Zucker Rats J. Nutr., March 1, 2005; 135(3): 499 - 504. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Mollard, H. R. Kovacs, S. C. Fitzpatrick-Wong, and H. A. Weiler Low Levels of Dietary Arachidonic and Docosahexaenoic Acids Improve Bone Mass in Neonatal Piglets, but Higher Levels Provide No Benefit J. Nutr., March 1, 2005; 135(3): 505 - 512. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A Weiler and M. C Kruger Polyunsaturated fatty acids and bone mass Am. J. Clinical Nutrition, October 1, 2004; 80(4): 1085 - 1086. [Full Text] [PDF] |
||||
![]() |
H. M MacDonald, M. H. Golden, D. M Reid, and S. A New Reply to HA Weiler and MC Kruger Am. J. Clinical Nutrition, October 1, 2004; 80(4): 1086 - 1087. [Full Text] [PDF] |
||||
![]() |
T. Okada Effect of cow milk consumption on longitudinal height gain in children Am. J. Clinical Nutrition, October 1, 2004; 80(4): 1088 - 1089. [Full Text] [PDF] |
||||
![]() |
H. Weiler Reply to T Okada Am. J. Clinical Nutrition, October 1, 2004; 80(4): 1089 - 1090. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |